Recombinant CCR2 (Plozalizumab Biosimilar) 抗体
Research Grade
适用: 人
ELISA
宿主: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- 抗原 See all CCR2 (Plozalizumab Biosimilar) products
- CCR2 (Plozalizumab Biosimilar)
- 抗体类型
- Recombinant Antibody
- 适用
- 人
-
宿主
-
Mammalian Cells
-
克隆类型
- 单克隆
-
标记
- This CCR2 (Plozalizumab Biosimilar) antibody is un-conjugated
- 应用范围
- ELISA
- 原理
- Plozalizumab Biosimilar - Anti-CCR2, CD192 mAb
- 产品特性
- Antibody Type: IgG1-kappa
- 质量等级
- Research Grade
- 亚型
- IgG1 kappa
-
-
- 限制
- 仅限研究用
-
- 缓冲液
- PBS pH 7.5
- 储存条件
- -80 °C
- 储存方法
- store at -80°C
-
- 抗原
- CCR2 (Plozalizumab Biosimilar)
- Abstract
- CCR2 (Plozalizumab Biosimilar) 产品
- 物质类
- Biosimilar
- 背景
-
MLN-1202,anti-CCR2,hu1D9
Plozalizumab is a humanized monoclonal antibody that targets CCR2 chemokine receptors found on the surface of white blood cells such as macrophages and monocytes. Plozalizumab has been investigated to treat Atherosclerosis. CCR2 is supposed to play an important role in the trafficking of monocytes and macrophages to sites of inflammation. - CAS-编号
- 1610761-46-0
-
You are here:
